AlphaYouMB
Insider selling
Mpm Bioventures 2018, L.P. sold $1.9M of Entrada Therapeutics, Inc. (TRDA) stock
Mpm Bioventures 2018, L.P., 10% owner of Entrada Therapeutics, Inc. (TRDA), sold 259,837 shares of TRDA stock worth $1.9M, per an SEC Form 4 filed Sep 9, 2026.
It was an open-market sale.
The trade happened on Sep 4, 2026, 5 days before it was made public.
TRDA has moved -6.9% since the trade date, from $7.13 to $6.64 (Sep 21, 2026 close).
- Traded
- Sep 4, 2026
- Disclosed
- Sep 9, 2026
- Filing delay
- 5 days
- Price since
- -6.9%
- Role
- 10% owner
- Source
- SEC Form 4
More TRDA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.